Nyxoah’s (NYXH) Sell (D-) Rating Reaffirmed at Weiss Ratings

Nyxoah (NASDAQ:NYXHGet Free Report)‘s stock had its “sell (d-)” rating reissued by stock analysts at Weiss Ratings in a note issued to investors on Saturday,Weiss Ratings reports.

Nyxoah Trading Down 1.1%

Shares of NYXH opened at $5.61 on Friday. The stock has a market capitalization of $191.08 million, a P/E ratio of -2.44 and a beta of 1.53. The company has a quick ratio of 2.38, a current ratio of 2.63 and a debt-to-equity ratio of 0.29. The firm has a fifty day simple moving average of $5.65 and a two-hundred day simple moving average of $6.62. Nyxoah has a twelve month low of $4.34 and a twelve month high of $11.87.

Nyxoah (NASDAQ:NYXHGet Free Report) last announced its quarterly earnings results on Monday, August 18th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.62) by ($0.01). The firm had revenue of $1.58 million for the quarter, compared to analysts’ expectations of $1.33 million. Nyxoah had a negative net margin of 1,541.84% and a negative return on equity of 79.18%. On average, research analysts anticipate that Nyxoah will post -1.91 EPS for the current year.

Institutional Investors Weigh In On Nyxoah

Institutional investors and hedge funds have recently modified their holdings of the stock. Kovack Advisors Inc. lifted its position in shares of Nyxoah by 16.5% in the 1st quarter. Kovack Advisors Inc. now owns 23,295 shares of the company’s stock worth $163,000 after purchasing an additional 3,295 shares during the period. Shay Capital LLC purchased a new stake in shares of Nyxoah in the 2nd quarter worth about $374,000. Raymond James Financial Inc. purchased a new stake in shares of Nyxoah in the 2nd quarter worth about $70,000. Bank of America Corp DE lifted its position in shares of Nyxoah by 72.4% in the 2nd quarter. Bank of America Corp DE now owns 7,866 shares of the company’s stock worth $59,000 after purchasing an additional 3,303 shares during the period. Finally, Franklin Resources Inc. lifted its position in shares of Nyxoah by 0.9% in the 2nd quarter. Franklin Resources Inc. now owns 294,990 shares of the company’s stock worth $2,207,000 after purchasing an additional 2,655 shares during the period.

About Nyxoah

(Get Free Report)

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

Featured Stories

Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.